Trial intelligence / Profile preview

Lactulose influence on gut microbiota

NCT02397512Completed

Sponsor
University of Zurich
Start
Feb 2015
Primary completion
Oct 2015
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised, single-blind trial of lactulose in constipation (2 arms), sponsored by University of Zurich. Primary endpoint: Influence of lactulose intake on gut microbiota composition. Started Feb 2015; status: completed.

02

Drugs

lactulose
03

Conditions

constipation

Beyond the preview

Go deeper on NCT02397512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02397512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call